Drug intelligence / Profile preview

Preventan

Development stage
Unknown
Lead developer
Farmax
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

Preventan is a dietary supplement and nutraceutical primarily marketed for the enhancement of the immune system's first line of defense. Developed by Farmax (now part of SVUS Pharma), its core component is **ProteQuine**, a proprietary complex consisting of nucleotides, amino acids, and oligopeptides derived from bovine sources. The supplement is typically formulated as lozenges designed to be dissolved in the mouth, allowing the active ingredients to interact directly with the mucosal surfaces of the oral cavity. The primary mechanism of action involves the stimulation of **secretory immunoglobulin A (sIgA)** production on the mucous membranes, which plays a critical role in neutralizing viral and bacterial pathogens before they can penetrate the respiratory epithelium. It is frequently used for the prevention and supportive management of the common cold and other upper respiratory tract infections.

Brand names
PreventanPreventan AkutPreventan JuniorPreventan QuattroPreventan Clasic
Other names
ProteQuine
02

Targets

sIgA (Secretory immunoglobulin A)

Beyond the preview

Go deeper on Preventan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preventan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call